Issue 1-2/2025

Nuclear factor I-C aggravates acute myelogenous leukemia by inhibiting SRY-box transcription factor 1 to activate autophagy

Cong Luo, Zeyu Luo, Junjun Li, Feng Wen, Yixiong Cao, Qiong Liu,  Xingxing Long

DOI: doi:10.4149/neo_2025_240905N376

Inhibition of enzymatic activity of HRD1 results in death of cells derived from glioblastoma multiforme, neuroblastoma, and normal astrocytes

Jaroslava Guzikova, Monika Liskova, Lubos Hudak, Maria Brodnanova, Andrea Evinova, Jozef Hatok,  Peter Racay

DOI: doi:10.4149/neo_2025_241120N481

Elevated expression of HSF1 promotes the progression of colorectal cancer by activating CLDN3 transcription

Yanxi Shao, Ting Ma, Dening Ma, Lue Hong, Min Lv, Shiqi Zhou, Zhibin Fang, Enyan Yu,  Xia Li,  Yuping Zhu

DOI: doi:10.4149/neo_2025_241031N442

Research progress on the regulation mechanism of DEPTOR expression and its role in tumorigenesis

Jinni Jiang, Chengyu Zhao, Minglei Yang,  Guofang Zhao,  Jianfeng Shu

DOI: doi:10.4149/neo_2025_241203N504

20(S)-ginsenoside Rg3 induced the necroptosis of prostate cancer cells via ROS overproduction

Yanfei Peng, Yaping Guo, Shuwu Zhao, Hao Yan, Zheng Hao, Fang Zheng, Zhaiyi Zhang, Lin Miao,  Li-kang Sun,  Muriel Cuendet

DOI: doi:10.4149/neo_2025_240925N402

Triptonide inhibits the progression of oral squamous cell carcinoma by suppressing the TRIP13/c-Myc axis

Hongbo Zhang, Zheng Wei, Shengwei Han,  Sufeng Zhao

DOI: doi:10.4149/neo_2025_240918N387

Efficacy and prognostic factors of PD-1 inhibitors combined with apatinib in advanced diffuse gastric cancer

Beibei Chen, Huichen Zhao, Huihui Hu, Jinxi Huang, Yingjun Liu, Huifang Lv, Weifeng Xu, Jianzheng Wang, Caiyun Nie, Jing Zhao, Yunduan He, Saiqi Wang, Yuhang Wang,  Xiaobing Chen

DOI: doi:10.4149/neo_2025_241021N429